Industry’s reaction to the U.S. FDA’s draft guidance for remote regulatory assessments included a request for more clarity on when the agency would issue a post-assessment report, but the final ...

The Trump administration told researchers it was “releasing” them from their roles. It puts the future of the assessment, which is required by Congress, in doubt. By Brad Plumer and Rebecca Dzombak ...